XML 11 R17.htm IDEA: XBRL DOCUMENT

Concentrations	9 Months Ended
Sep. 30, 2013
Concentrations	(11) CONCENTRATIONS The Company sourced approximately 34% and 23% of its electrotherapy products from one contract manufacturer during the three and nine months ended September 30, 2013. Management believes that its relationships with suppliers are strong; however, if necessary these relationships can be replaced. If the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred. The Company had receivables from a private health insurance carrier at September 30, 2013 that made up approximately 7% of the net accounts receivable balance. The Company had receivable from a different private health insurance carrier that made up approximately 22% of net accounts receivable at December 31, 2012.

Concentrations

9 Months Ended

Sep. 30, 2013

(11) CONCENTRATIONS

The Company sourced approximately 34% and 23% of its electrotherapy products from one contract manufacturer during the three and nine months ended September 30, 2013. Management believes that its relationships with suppliers are strong; however, if necessary these relationships can be replaced. If the relationships were to be replaced, there may be a short-term disruption to operations, a period of time in which products may not be available and additional expenses may be incurred.

The Company had receivables from a private health insurance carrier at September 30, 2013 that made up approximately 7% of the net accounts receivable balance. The Company had receivable from a different private health insurance carrier that made up approximately 22% of net accounts receivable at December 31, 2012.

- Definition

The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.

+ References+ Details